Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

NCT06500247 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: Dalpicilib
DRUG: Abiraterone Acetate (II)
DRUG: Androgen Deprivation Therapy
DRUG: Prednisone

Sponsor

Qilu Hospital of Shandong University

Collaborators

[object Object]